S. Martínez González

Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.

J. Bischoff, R. Álvarez, M. I. Albarrán, 2017, Bioorganic & medicinal chemistry letters.

Design and Synthesis of a Series of Piperazine‐1‐carboxamidine Derivatives with Antifungal Activity Resulting from Accumulation of Endogenous Reactive Oxygen Species

J. Heeres, L. Meerpoel, J. Pastor, 2009, ChemMedChem.

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.

Identification of ETP-46321, a Potent and Orally Bioavailable PI3K α, δ Inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012 .

Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.

O. Rabal, J. Oyarzábal, J. Bischoff, 2012, Bioorganic & medicinal chemistry letters.

Identification of novel PI3K inhibitors through a scaffold hopping strategy.

J. Bischoff, C. Blanco-Aparicio, R. Álvarez, 2017, Bioorganic & medicinal chemistry letters.

Callosal agenesis, chorioretinal lacunae, absence of infantile spasms, and normal development: Aicardi syndrome without epilepsy?

S. Martínez González, J. P. Prats Viñas, M. M. Martínez González, 2005, Developmental medicine and child neurology.

Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.